share_log

Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.

Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.

Adaptimmune治疗公司股价上涨,此前该公司公布了好于预期的第二季度每股收益业绩,并重申了指导意见。
Benzinga ·  2022/08/04 14:56

Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.

Adaptimmune治疗公司股价上涨,此前该公司公布了好于预期的第二季度每股收益业绩,并重申了指导意见。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发